000 | 04476cam a2200565Ia 4500 | ||
---|---|---|---|
001 | ocn228148277 | ||
003 | OCoLC | ||
005 | 20141103172212.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 080516s2007 enkaf ob 001 0 eng d | ||
040 |
_aOPELS _beng _cOPELS _dOCLCQ _dOCLCF _dCHVBK |
||
020 | _a9780123694485 | ||
020 | _a0123694485 | ||
029 | 1 |
_aNZ1 _b12541708 |
|
029 | 1 |
_aDKDLA _b820120-katalog:000577709 |
|
029 | 1 |
_aDEBSZ _b405318618 |
|
029 | 1 |
_aCHVBK _b122271564 |
|
029 | 1 |
_aCHDSB _b005985912 |
|
035 | _a(OCoLC)228148277 | ||
037 |
_a114525:114618 _bElsevier Science & Technology _nhttp://www.sciencedirect.com |
||
050 | 4 |
_aRS431.A64 _bC36 2008eb |
|
060 | 4 | _a2008 A-287 | |
060 | 4 |
_aQV 269 _bN397c 2008 |
|
082 | 0 | 4 |
_a616.994061 _222 |
049 | _aTEFA | ||
245 | 0 | 0 |
_aCancer drug design and discovery _h[electronic resource] / _cedited by Stephen Neidle. |
250 | _a1st ed. | ||
260 |
_aNew York, NY : _bAcademic Press, _c2008. |
||
300 |
_a1 online resource (xv, 473 p., [27] p. of plates) : _bill. (some col.) |
||
520 | _aThe ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories. | ||
505 | 0 | _aSection I. Basic Principles -- 1. Modern cancer drug discovery: Integrating targets, technologies and treatments -- 2. Preclinical pharmacology and in vivo models -- 3. Clinical trial designs for more rapid proof-of-principle and approval -- Section II. Methodology -- 4. Structural biology and anticancer drug design -- 5. Natural product chemistry and cancer drug discovery -- 6. Pharmacokinetics & ADME optimization in drug discovery -- Section III. Drugs in the clinic and laboratory -- 7. Temozolomide: from cytotoxic to molecularly-targeted agent -- 8. Camptothecins for drug design, cancer cell death and gene targeting -- 9. Targeting thymidylate synthase by antifolate drugs for the treatment of cancer -- Section IV. New Agents -- 10. Targeting inactive kinases: structure as a foundation for cancer drug discovery -- 11. Cell cycle inhibitors in cancer: current status and future directions -- 12. Inhibition of DNA repair as a therapeutic target -- 13. Heat shock protein-90 inhibitors: targeting the cancer chaperone for combinatorial blockade of oncogenic pathways -- 14. Heat shock protein-90-directed therapeutics and target validation -- 15. Inhibitors of tumour angiogenesis -- 16. The biology and oncology of RAFERK signalling P53 as a therapeutic target -- Section V. The reality of cancer drugs in the clinic -- 17. Cancer drug resistance -- 18. Failure Modes in Anticancer Drug Discovery and Development. | |
504 | _aIncludes bibliographical references and index. | ||
588 | _aDescription based on print version record. | ||
650 | 0 |
_aAntineoplastic agents _xDevelopment. |
|
650 | 0 |
_aAntineoplastic agents _xDesign. |
|
650 | 0 |
_aCancer _xChemotherapy. |
|
650 | 7 |
_aAntineoplastic agents _xDesign. _2fast _0(OCoLC)fst00810598 |
|
650 | 7 |
_aAntineoplastic agents _xDevelopment. _2fast _0(OCoLC)fst00810599 |
|
650 | 7 |
_aCancer _xChemotherapy. _2fast _0(OCoLC)fst00845327 |
|
650 | 2 | _aAntineoplastic Agents. | |
650 | 2 | _aDrug Design. | |
650 | 2 |
_aNeoplasms _xdrug therapy. |
|
655 | 4 | _aElectronic books. | |
700 | 1 | _aNeidle, Stephen. | |
776 | 0 | 8 |
_iPrint version: _tCancer drug design and discovery. _b1st ed. _dNew York, NY : Academic Press, 2008 _z9780123694485 _z0123694485 _w(OCoLC)154760280 |
856 | 4 | 0 |
_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9780123694485 |
942 | _cEB | ||
994 |
_aC0 _bTEF |
||
999 |
_c20999 _d20999 |